Published in
Elsevier, Transplantation and Cellular Therapy, 2023
DOI: 10.1016/j.jtct.2023.02.010
Links
Tools
A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation
Journal article published in 2023 by
Armin Rashidi,
Eric J. Huselton 
,
Heather E. Stefanski,
Todd E. DeFor,
Ryan Shanley ,
Jaebok Choi ,
John F. DiPersio,
Mark Juckett ,
Jeffrey S. Miller,
Daniel J. Weisdorf ,
Mark A. Schroeder
,
Heather E. Stefanski,
Todd E. DeFor,
Ryan Shanley ,
Jaebok Choi ,
John F. DiPersio,
Mark Juckett ,
Jeffrey S. Miller,
Daniel J. Weisdorf ,
Mark A. Schroeder
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 